Skip to main content
. 2019 Aug 13;116(35):17429–17437. doi: 10.1073/pnas.1909550116

Fig. 6.

Fig. 6.

RG7112 pretreatment does not adversely affect treatment outcomes. (Upper) Transplant tumor growth in wild-type mice carrying MMTV-Wnt1 tumors with wild-type p53 with and without RG7112 treatment. (Lower) Transplant tumor growth in wild-type mice carrying MMTV-Wnt1 tumors with mutant p53R172H with and without RG7112 treatment.